Another possible mechanism of estrogen-mediated resistance to HCC may involve the hepatic metabolism of estrogen by Cytochrome P450 1a2, leading to protective metabolites that affect rates of proliferation and apoptosis in HCC [75]. This evidence concerns the gene CYP1A2 and hepatocellular carcinoma.